Assembly biosciences reports first quarter 2022 financial results and recent highlights

South san francisco, calif., may 12, 2022 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a clinical-stage biotechnology company developing innovative, investigational therapeutics targeting hepatitis b virus (hbv) and other viral diseases, today reported financial results and recent highlights for the first quarter ended march 31, 2022.
ASMB Ratings Summary
ASMB Quant Ranking